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ABSTRACT
The Bispectral Index (BIS) technology developed by Aspect Medical Systems is
Food and Drug Administration approved and commercially available to monitor the
effects of anesthetics and sedatives on the level of consciousness in the Operating Room,
Intensive Care Unit (ICU), and in special procedure environments where sedation is
administered. Sedation management is a challenge in the ICU with serious consequences
resulting from oversedation or undersedation. A literature review provides evidence that
the BIS is a reliable, valid tool for objective sedation assessment in the ICU. However,
critical care nurses must be able to first identify which patient populations can benefit
from BIS use. Then, nurses must understand this technology to appropriately interpret the
data within the context of the clinical situation. Knowledge of the BIS is essential as
nurses often direct sedation management after initial physician’s orders for sedation have
been received. To date, there are no established research-based guidelines for nurses
regarding BIS use in the critical care setting. This independent study explored this
knowledge gap and developed a procedure and skill competency validation to optimize
BIS utilization by critical care nurses in the ICU. The procedure and skill competency
validation was received well by the critical care nurses. The post-implementation
evaluation provided evidence that the critical care nurses were competent and willing to
utilize BIS technology effectively to promote optimal sedation management.
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CHAPTER I
INTRODUCTION
Sedation management is a challenge in the Intensive Care Unit (ICU) with serious
consequences resulting from oversedation or undersedation. The Bispectral Index (BIS)
technology is a product of Aspect Medical Systems that was developed to optimize
sedation use. Founded in 1987, the company began developing technology to directly
measure the effects of drugs and disease on the brain (Aspect Medical Systems, Inc.,
2002). The BIS received marketing clearance from the Food and Drug Administration
(FDA) as a measure of anesthetic effects in October of 1996 (Aspect Medical Systems,
Inc., 1997). Initially introduced into the operating room, use of the BIS has now
expanded into the ICU and special procedure environments.
Since its early development, the BIS has been studied regularly. Publications on
the BIS date back to 1991, with references in 219 articles in 2003 alone. On-going
research continues to define and explore the applications of this technology. As a tool
providing objective sedation data, the BIS has been shown to correlate with and
compliment proven subjective sedation tools. The BIS converts an electrical signal,
obtained via electrodes placed on the patient’s forehead, into a digital reading that ranges
from 0 to 100. A reading of zero indicates lack of electric brain activity, and a reading of
100 indicates a fully awake state. The ability of this technology to quickly and easily
provide data regarding the degree of brain activity, or level of arousal, makes it useful to
monitor ICU patients that are less arousable due to sedating medications or neurological
changes. While the BIS is marketed strictly as a measurement of sedation, there are

additional applications being researched. The ability of the BIS to provide objective
sedation monitoring in the ICU enables the nurses who utilize it to more comprehensively
meet sedation goals for their patients. However, nurses’ knowledge of the BIS and their
ability to identify patient populations that can benefit from its use affects the extent to
which it may potentially influence practice. By educating critical care nurses with a
procedure and skill competency validation (SCV) for BIS technology, optimal BIS use is
enhanced.
Clinical Problem
A review of the literature provides evidence that the BIS is a reliable, valid tool
for sedation assessment in the ICU. The BIS, however, like all other medical monitoring
equipment, must be interpreted within the context of the clinical situation by a health care
professional. Surveys of ICUs have identified that the ICU nurse often directs
management of sedation after the initial physician’s orders for sedation have been
received (Weinert, Chian, & Gross, 2001). When BIS monitoring is utilized, nurses must
be knowledgeable about its indications, usage, and limitations. To date, there are no
available studies that establish guidelines for use of this new technology in the ICU. This
independent study explored this knowledge gap and thereby developed a research-based
procedure and SCV for critical care nurses regarding BIS use in the ICU.
Purpose of the Independent Study
The purpose of this independent study was to develop a procedure and SCV for
BIS utilization in the ICU by critical care nurses in relation to the concepts of sedation
and analgesia. The BIS procedure that was developed directs nursing’s use of BIS in the
ICU and was implemented concurrently with a SCV for nursing that aims to provide
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consistent education to critical care nurses regarding BIS technology usage and
limitations. Following implementation of the BIS procedure and SCV, critical care nurses
were asked to complete an evaluation tool that assessed the usefulness of the procedure
and SCV for directing their use of BIS in clinical practice and provided an assessment of
their understanding of the education they received. Analysis of this data provided insight
into critical care nurses’ comfort with providing sedation monitoring via BIS in the ICU.
Additionally, this assessment of nursing knowledge regarding the procedure and SCV
provides data to facilitate further education. Successful implementation of the BIS
procedure and SCV for critical care nurses is essential to helping nurses effectively
utilize this equipment and optimize sedation management for their patients.
Conceptual Framework
A physiological framework guides this independent study. An understanding of
the physiology of electrical activity in the brain (cerebral electrical activity) is vital to
recognize the mechanism by which the BIS directly measures the effects of sedating
drugs on the brain. Additionally, analgesia is a frequent adjunct to sedative therapy. Thus,
the physiology of pain, or nociception, provides the foundation for the potential
application of the BIS as an indirect measurement of the effects of analgesia on the brain.
Physiology o f Cerebral Electrical Activity
The brain is able to integrate internal and external stimuli and respond via
descending neural transmissions to regulate all human behavior (Hansen, 1998). The
brain consists of the cerebrum, brain stem, and cerebellum. The cerebrum includes the
cerebral cortex, the outer gray matter that consists of cell bodies of neurons. Neurons are
specialized cells of the neurologic system that consist of a cell body, multiple afferent
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fibers (dendrites), and a single efferent fiber (axon). Neurons are responsible for
generating and conducting the neural transmissions that occur across a space known as
the synapse. This synaptic transmission requires the stimulus, or action potential, from
the first neuron to release a chemical substance (neurotransmitter) that crosses the
synapse and binds with the receptor of a second neuron, potentially resulting in another
action potential (excitatory postsynaptic potential) or inhibiting it from occurring
(inhibitory postsynaptic potential). The rate of impulse transmission through the brain
stem is controlled by the reticular activating system (RAS), located in the brain stem.
Therefore, Hansen states, “The capacity of the cortical centers to respond to stimuli is
governed by the RAS, which mediates consciousness, or the ability to experience the
environment” (p. 577). Both wakefulness and awareness require increased activation of
the cortex by ascending impulses from the RAS in the brain stem up to the cortical
centers in the cerebrum (Hansen). An electroencephalograph can provide a graphical
record of cerebral electrical activity known as an electroencephalogram (EEG).
By placing electrodes on the brain or outer surface of the skull, the summed
membrane potentials generated during neurotransmission can be recorded via the EEG.
Hansen (1998) noted that the EEG primarily detects inhibitory and excitatory
postsynaptic potentials rather than action potentials when the waveforms are generated
due to the direction of electrical activity in relation to the lead axis formed by two
electrodes. The four resulting characteristic brain wave patterns include: “(1) alpha,
associated with an awake, but quiet brain; (2) beta, seen over areas of intense activity or
REM sleep; (3) theta, associated with stress, frustration and some sleep states; and (4)
delta, seen during deep sleep” (Hansen, p. 579). Normal fluctuations in brain wave
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characteristics are seen with changes in activity type and intensity or sleep. Additionally,
since electrical activity in the two hemispheres of the cerebrum is synchronized by a
mechanism involving the thalamus (area of gray matter deep in the cerebrum),
differences between the hemispheres can be used to detect localized damage or other
cerebral abnormalities (Martini, 1998). In view of the fact that the EEG has the potential
to measure cerebral activity, it has long been the focus of research on the effects of drugs
and disease on the brain. This research has lead to the development of the BIS
technology.
The evolution of the BIS began with analysis of the bifrontal EEG recordings of
more than 5000 subjects sedated with different anesthetics according to three variables:
(a) burst suppression ratio, a quantification of electrical silence during deep anesthesia;
(b) relative alpha/beta ratio, frequency bands often seen during light sedation; and (c)
bicoherence of the EEG, a description of the phase coupling relations between individual
waves in which a high biocoherent value may be associated with moderate sedation
(Chan & Gin, 2000). Since the BIS was developed using only segments of artifact-free,
non-suppressed EEG, further EEG data from more than 400 intraoperative patients
(>1,000 hours) that included both artifact-free and noise corrupted/suppressed EEG was
evaluated to trend sedation in a sample more representative of the clinical setting (Aspect
Medical Systems, Inc., 1997). These studies determined BIS to be a quantifiable measure
of the effects of anesthetics on the brain that correlates to the level of consciousness and
probability of recall (Aspect Medical Systems, Inc.).
The process of deriving the BIS number from bispectral analysis of the EEG is
complex. This complexity evolved as the difficulties encountered with use of the EEG as
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a clinical measurement of anesthetic state were addressed. EEG monitoring problems
included varying effects on the EEG with increasing concentrations of different drugs
(i.e. propofol and midazolam), the use of drug combinations that left the corresponding
value of the EEG measure unknown, and the burst suppression follow ed by isoelectricity
(lack of cerebral electrical activity) with high drug concentrations created computational
problems for spectral approaches (Billard et ah, 1997). Billard et al. (1997) state, “The
ideal measure [of anesthetic state] should be independent of the drugs given, take account
of burst suppression, and have a monophasic time course during the administration of
anesthetic drugs” (p. 46). Therefore, the real-time BIS computation consists of three
analysis steps. First, the EEG pre-processor breaks the EEG signal down to the second
and identifies and excludes segments with artifact and suppressed EEG (Aspect Medical
Systems Inc., 1997). Next, a sophisticated algorithm calculates the hypnosis/sedation
index by combining selected EEG features (Aspect Medical Systems, Inc. ). Finally, the
hypnosis/sedation index is modified to better reflect the level of suppression in the EEG,
with the suppression ratio (SR) computed separately as the percentage of suppressed EEG
in the non-artifact data over the last minute (Aspect Medical Systems, Inc.).
The ability of the BIS to measure the consistency of phase and power
relationships among the various frequencies of the EEG and handle burst suppression
allows it to adequately trend different EEG responses to different drugs and combinations
of those drugs; for example, propofol and midazolam (Billard et al., 1997). With
increasing concentrations, propofol induces an increase in frequency and amplitude,
followed by EEG slowing and decreased amplitude, and finally, burst suppression. In
contrast, midazolam increases EEG frequency and amplitude (Billard et al.). These EEG
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descriptions contrast somewhat with the EEG characteristics of sedation identified by
Aspect Medical Systems, Inc. (1997): “EEG sedation measures have been developed
based on the observation that the EEG generally changes from a low amplitude, high
frequency signal while awake to a large amplitude, low frequency signal when deeply
anesthetized.” Nevertheless, the ability of the BIS to take into account the variability of
drug response on the EEG has been shown by the research of Billard et al. BIS was able
to optimize tracking of EEG changes associated with different anesthetic states, allowing
subsequent improvement of the calculation algorithm to include different anesthetic drugs
and provide better correlation with hypnotic drug effects (Billard et al.). In fact, Chan and
Gin (2000) noted that the only exception to BIS sedation monitoring of anesthetic
combinations is ketamine and nitrous oxide.
In summary, the BIS digitalizes and transforms the EEG into amplitude and phase
relationships with a technique known as Fourier transfonnation, then averages the EEG
over time on the basis of phase relationships among harmonic frequencies (Billard et al.,
1997). “The resulting multivariate response vector was then reduced to the univariate
‘bispectral index’ through an algorithm of weighting coefficients” (Billard et al., p. 47).
The complexity of this process underscores the potential for a knowledge deficit
regarding BIS applications and limitations. It is unlikely that the majority of healthcare
professionals utilizing the BIS understand the computation of the data to this extent, and
this complexity is precisely what makes traditional EEG monitoring and interpretation
unrealistic in the ICU. Therefore, while it is unrealistic to expect critical care nurses to
fully comprehend the BIS calculations, they must be aware that correlation of all
available monitor data, not just the BIS number, with the clinical situation is indicated.
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Additional BIS data includes a visual quantification of electromyographic (EMG)
activity (a potential interference); signal quality index (SQI) of the recorded data (the
percentage of the last minute that had usable data); and suppression ratio (SR) (the
percentage of the last minute that had isoelectric activity). As stated by De Deyne et al.
(1998):
When measuring EEG in an ICU, it is important to assess the quality of the EEG
signal. There are many problems with signal bias due to electrical interference
from other equipment used in the ICU. So, when evaluating a new monitoring
device, it is important to assess signal quality and accuracy, (p. 1295)
While the study findings of Bruhn, Bouillon, and Shafer (2001) noted BIS values
between 30 and 40 did not adequately reflect increased drug effect, the authors state that
awareness of new burst suppression or an increase in the SR with an unchanged BIS
could highlight this problem. In another study of six patients receiving pentobarbital
infusions to induce a barbiturate coma, mean BIS values of 15 correlated well with the
number of bursts per minute quantifying the degree of EEG suppression (Riker, Wilkins,
& Fraser, 1999). Further implications of additional monitor calculations (i.e. SR, EMG,
SQI) beyond the BIS value, and the need for acknowledgement of all available data is
discussed in the review of the literature.
Physiology o f Pain
The review of the literature also holds evidence that BIS technology may have a role
in pain management. Narcotics are frequently used to treat pain in the ICU. They exert
analgesic effects by binding to specific receptors in the brain, spinal cord, and peripheral
tissue (Arbour, 2000a). Commonly used narcotics, including morphine sulfate, fentanyl
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citrate, hydromorphone, and meperidine hydrochloride, reduce pain perception by their
action in the central nervous system (CNS).
For the purpose of this study, the physiologic basis of pain sensation will be
communicated. Although not described herein, it should be noted that psychological and
sociocultural components influence pain sensation. Truly, pain is a subjective experience;
pain is what the experiencing individual says it is. The International Association for the
Study of Pain (1994) defines pain as, “An unpleasant sensory and emotional experience
associated with actual or potential tissue damage, or described in terms of such damage”
(Pain Terms section, para. 1). Nociceptors are free nerve endings that serve as receptors
for the noxious, or unpleasant, stimuli that are perceived as painful. When stimulated,
nociceptors transmit impulses to the brain via the ascending anterolateral pathway in the
spinal cord (Hansen, 1998). The pain sensation is received by the primary sensory cortex
(area of the brain located in the parietal lobe) and is perceived in the adjacent sensory
association areas (Hansen). Any sensory event, including pain, launches an extensive
network of brain systems working both sequentially and in parallel (Crawfor, Knebel, &
Vendemia, 1998).
The intensity of pain sensation may be reduced by the endogenous analgesia system.
This descending pathway originates in two areas of the brain stem, the periaqueductal
gray area of the midbrain and the RAS, where many receptors for endogenous opioids are
located (Hansen, 1998). Endogenous opioids are natural, innate substances that bind to
the same opioid receptors as narcotic analgesics. This impulse is transmitted by motor
axons descending from these areas in the brain stem to neurons in the spinal cord that
synapse on second-order neurons of the pain pathways (Hansen). It is the blocking of
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some ascending pain transmissions at these second-order sensory neurons that results in
the decreased sensation of pain by the brain. Thus, while pain sensation and perception
occurs in the brain, the arrival of the pain stimulus in the brain is dependent upon
transmission via the spinal cord.
The extensive electrical activity produced by pain sensation and perception in the
brain could be recorded with EEG monitoring. While narcotics interfere directly with
pain transmission at the level of the spinal cord, the indirect effect this has on cerebral
sensation and perception of pain will affect cerebral electrical activity. Consequently, BIS
technology has the potential to indirectly measure changes in cerebral electrical activity
produced by the effects of analgesia.
Significance of the Independent Study: Clinical Implications
Improved patient outcomes, following advances in patient sedation monitoring
such as the BIS, is dependent upon nursing awareness, understanding, and willingness to
use this new technology. To optimize BIS utilization and effectiveness in the ICU, it is
essential to implement a consistent, research-based procedure and SCV for its use that
will provide critical care nurses a guide for objective sedation management.
Optimizing sedation management in the ICU not only improves patient outcomes,
it reduces sedative costs. Devlin et al. (2001) found that more than 90% of critically ill
patients receive sedation and analgesia in the ICU, with associated costs greater than $1
billion per year. These sedative drug costs represent 10-15% of all ICU drug costs
(McGaffigan, 2002). Kaplan and Bailey (2000) were able to reduce costs of sedation by
18% when they titrated sedative infusions to a BIS value between 70 and 80 instead of
titrating sedation to patient comfort guided by vital sign changes after stimulation. In this
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study, only 15.4% of the 26 patients were under-sedated by BIS analy sis, while 54% of
patients required less sedative than initially predicted by the staff (Kaplan & Bailey). The
potential impact of medication cost savings demands attention.
Greater yet is the need to optimize sedation with the potential to eliminate costly
adverse effects of oversedation and undersedation, with respect to both needless use of
financial resources and poor patient outcomes (Leur, 2002; Epstein, 1999). Oversedation
is known to increase an already expensive length of stay in the ICU, with accompanying
complications such as the need for a tracheostomy or susceptibility to nosocomial
infections. While undersedation is linked to patient discomfort and anxiety, the effects of
undersedation may be financially costly as well. The estimated cost associated with
patient-initiated medical device removals in the ICU, such as gastrointestinal tubes and
vascular catheters, has been estimated at $181 per event; translating to an estimated
annual cost of more than $250,000 for the 42-bed ICU studied (Fraser, Riker, Prato, &
Wilkins, 2001). Agitation had been documented within the two hours prior to patientinitiated device removal in 74% of the occurrences (Fraser et al., 2001). Most
complications resulting from oversedation and undersedation are preventable and
correctable. BIS monitoring provides an objective tool to assist nurses with sedation
assessment. Through successful implementation of a research-based procedure and SCV
for critical care nurses, steps will be taken to ensure that the advantages of optimal
sedation management with BIS in the ICU may become a reality.

Assumptions
Core assumptions of this independent study include:
1. Critical care nurses are familiar with the common medical terminology utilized
in the BIS procedure and SCV and the post-education evaluation tool (BIS terminology is
explained by the skill validation).
2. Participants answered the post-implementation evaluation tool questions
truthfully, without input, discussion, or comparison with other participants.
3. Critical care nurses have the authority to titrate sedation based on sedation
assessment data to the level of sedation ordered by the physician unless a specific rate is
ordered.
4. Critical care nurses are aware of the current facility procedures and SCVs
regarding sedation management in the ICU in which they are employed arid are
concerned with obtaining and maintaining knowledge of them.
5. Critical care nurses aim to provide optimal sedation management for their
patients.
Limitations
The following characteristics of this independent study are limitations:
1. The ultimate decision as to whether or not the BIS should be utilized on a
patient will be made by the critical care nurse or physician and may override facility or
unit policies and procedures.
2. The use of an evaluation tool has inherent limitations in that participants may
have provided answers in a manner that does not reflect their actual knowledge and
attitudes toward the procedure and SCV.
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Summary
The objective of the BIS procedure and SCV that was developed for this
independent study was to provide research-based guidelines for nurses regarding BIS use
in the ICU. The responses of the critical care nurses to this project was addressed by an
evaluation of the BIS Procedure and Skills Validation. This evaluation was completed by
the ICU nurses after their individual instruction on the BIS Procedure and SCV. These
results are discussed in Chapter IV of this paper.
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CHAPTER II
REVIEW OF THE LITERATURE
Due to the limited knowledge regarding nursing practices surrounding sedation,
especially regarding the use of BIS technology, applications of the BIS in the ICU as a
basis for nursing knowledge of this technology are addressed in this review of the
literature. Additionally, this review provides a research base from which the established
use of BIS in the ICU was interpreted to develop of a procedure and SCV for its use. The
BIS has a role in the ICU as the use of sedation and therapies requiring sedation are
indicated for many critically ill patients. The stress of critical illness, medical
interventions involving sedation to promote compliance with care, the need for adequate
sedation assessment and management, and the applications of the BIS in the ICU are
discussed.
Stress of Critical Illness
Critical illnesses are associated with pain, hypotension, hypoxemia, and tissue
injury, resulting in increased stress hormone circulation from the Sympathetic Nervous
System (SNS) (Epstein & Breslow, 1999). Once seen as an adaptive mechanism to
achieve homeostasis, Epstein and Breslow argue: “The need for an endogenous stress
response is less clear in the setting of precise and technically sound surgical repair,
judicious fluid administration and resuscitation, steady hemodynamics, and the provision
of alternative fuel substrates” (p. 24). In fact, the need to attenuate the stress response is
obvious when considering its potential physiologic risks. Cardiovascular complications
alone include hypertension, tachyarrythmias, myocardial ischemia, infarction, and

congestive heart failure with hypervolemia (Epstein & Breslow). Additional metabolic
alterations of blood glucose and the catabolism of protein; hematologic alterations of
hypercoagulability with DVT development, and of abnormal immune function; renal and
electrolyte alteration leading to hypervolemia and the development of hypokalemia and
hypomagnesemia, respectively, all lead to further complications in treatment of the
critically ill.
In addition to their involvement in activating the stress response, prolonged pain
and anxiety lead to increases in global oxygen consumption, production of carbon
dioxide, and metabolic rate (Arbour, 2000b). Furthermore, psychological consequences
of prolonged pain and anxiety include increased perception of pain, further anxiety, and
fear (Arbour, 2000b). Untreated anxiety leads to heightened perception of pain, an
increased arousal state, and further mobilization of the stress response (Arbour, 2000b).
Therefore, medical interventions for anxiety and pain are fundamental to successful
patient outcomes. The mounting evidence of adverse effects related to anxiety and pain is
not going unnoticed. More than ever, nurses need to promote patient comfort.
McGaffigan (2002) explains:
This heightened focus on promoting comfort has been driven by a growing body
of evidence around the adverse effects of anxiety and pain, increased regulatory
scrutiny from organizations such as the Joint Commission on Accreditation of
Healthcare Organizations [JCAHO] and growing consumer awareness that
provision of quality care includes optimal comfort, (p. 29)
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Indications for Sedation Use
While the best intervention is to address the cause of the patient’s difficulty (pain,
anxiety, agitation, ventilator intolerance, etc.) and improve the circumstances nonpharmacologically, such measures may not remedy the situation. Sedation may be
empirically initiated to dull the pain and anxiety produced by invasive life-supporting and
monitoring devices, with opioid analgesics also incorporated to provide synergistic
sedation or respiratory depression that will blunt cough or diaphragmatic movements
hindering optimal mechanical ventilation (Leur, 2002). Anxiety and pain caused by
critical illness may be manageable with intermittent sedation and analgesia, respectively,
but continuous invasive therapies require continuous use of sedation and analgesia to
consistently meet patient needs.
Asynchrony with the ventilator, or intolerance of positive-pressure ventilation
otherwise known as “bucking the vent,” occurs frequently and leads to patient
discomfort, anxiety, and agitation. Other causes of agitation in the ICU are numerous,
including invasive procedures, confusion, and sleep deprivation. Uncontrolled agitation
interferes further with mechanical ventilation, and may also cause myocardial and
cerebral ischemia, self-extubation, the removal of invasive medical devices, and inability
to contribute to assessments and therapy (Devlin, Fraser, Kanji, & Riker, 2001). The use
of sedation and analgesia is instituted to alleviate anxiety and pain, while promoting rest
and facilitating optimal medical management. The ability of sedation to assist in
ventilator compliance is demonstrated by the correlation between lack of intravenous
sedation with a 10.8% rate of unplanned extubation in 426 ventilated patients over a twomonth period (Boulain & the Association des Reanimateurs du Centre-Quest, 1998).
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When the progressive use of nonconventional, controlled ventilator modes that do not
allow patient assistance and partial support are even less tolerated, deeper sedation and
neuromuscular blockade maybe indicated (Simmons, Riker, Prato, & Fraser, 1999;
Arbour, 2000b).
Neuromuscular Blockade
When neuromuscular blockade is used in the ICU, the extent of muscle paralysis
achieved is comparable to that in the OR setting (Wheeler, 1993). This helps to achieve
the desired goals of ventilation with patients who have persistent, severe hypoxemia
related to respiratory disease, are extremely agitated, or require complex ventilator modes
in which respiratory effort must be controlled (Leur, 2002). Muscle paralysis, however,
leaves the patient unable to demonstrate anxiety and pain.
Both Arbour (2000a) and Leur (2002) recognize the importance of anxiety and
pain prevention, emphasizing the need to establish aggressive baseline sedation and
analgesia prior to administering neuromuscular blocking agents. It should be noted that
peripheral nerve stimulation techniques, such as the train-of-four (TOF) method, that
monitor the level of muscle paralysis during neuromuscular blockade do not in any way
provide data regarding the level of sedation and/or analgesia. During therapy with
neuromuscular blockade, sedation and analgesia needs may change due to tolerance or
changes in patient condition. It has been recommended that therapy with neuromuscular
blocking agents be periodically interrupted to assess sedation needs (Leur), yet the BIS
technology provides objective sedation assessment without disrupting the desired course
of treatment. Additionally, patients’ level of sedation may vary during the active intervals
of neuromuscular blockade when sedation assessment is unavailable.
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Studies have identified up to 40% of patients receiving sedation and analgesia
who had vivid and accurate recall of being awake, anxious, and in pain while paralyzed
leading to potential development of post-traumatic-stress disorder (PTSD) (Arbour,
2000c). Hemodynamic parameters such as tachycardia and hypertension, as well as
lacrimation and diaphoresis, all of which indicate increased SNS activity, are noted to be
indicative of anxiety and pain, decreasing when sedation and analgesia is implemented
(Arbour, 2000c; Leur, 2002). While these changes provide valuable information, they are
indirect measures of sedation that are unpredictable, influenced by concurrent drug
therapy and changes in the patient’s condition, and variable between patients (Arbour,
2000c; Arbour, 2000a; McGaffigan, 2002).
BIS technology can now provide objective sedation assessment throughout
neuromuscular blockade therapy, allowing sedation to be titrated to meet more
identifiable changing needs. However, there have been concerns regarding
appropriateness of BIS monitoring of sedation for patients receiving neuromuscular
blocking agents since BIS calculation involves analysis of electromyographic activity in
the facial muscles. A study of 10 healthy volunteers that received propofol anesthesia and
mivacurium (nondepolarizing neuromuscular blocking agent) to produce varying levels
of neuromuscular blockade for each volunteer found that, at a significance level of
p< 0.05, the BIS was comparable at all designated block levels; with no alteration of BIS
by either reducing electromyographic artifact or by decreasing afferent neuronal input
(Greif et al., 2002). Thus, Greif et al. disproved their hypothesis that nondepolarizing
neuromuscular block reduces BIS, and concluded that BIS comparably estimates sedation
in subjects who are paralyzed, partially paralyzed, or unparalyzed.
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Barbiturate Coma
Barbiturate comas implemented in the ICU also present a challenge for sedation
management. Barbiturates reduce cerebral oxygen requirements in patients with
refractory intracranial hypertension, but due to hypotension at higher doses blood flow to
the brain can actually worsen, demanding careful titration. EEG monitoring is frequently
used to titrate pentobarbital infusions to a burst-suppression pattern (Riker, Wilkins, &
Fraser, 1999). The complex standard EEG monitoring that can be impractical in the ICU
and requires expert electroencephalographic interpretation may be replaced with the BIS.
Riker, Wilkens, and Fraser implemented BIS monitoring of six patients over 25 patientdays in which pentobarbital infusions were titrated to attain a specific burst-suppression
pattern. Findings indicate that data including a raw EEG signal as well as continuous
processed EEG data such as the BIS and SR, worked well to facilitate this titration
(Riker, Wilkens, & Fraser).
Sedation Assessment and Management
Excessive or inadequate levels of sedation create negative outcomes for patients.
Oversedation is linked to delayed recovery, prolonged intubation, and increased length of
stay in the ICU (Arbour, 2000b; McGaffigan, 2002). Each of these outcomes further
results in a magnitude of potential complications. Inadequate sedation and concurrent
analgesia may permit the adverse effects of anxiety and pain, respectively, to continue
(Arbour, 2000b; Epstein & Breslow, 1999). Sedation assessment to provide optimal
sedation management is a must.
Sedation delivery, although initially ordered by a physician, often becomes the
responsibility of the bedside nurse. Frequently, the sedation order lacks a distinct
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indication for use and/or a definitive therapeutic goal (Dasta, Fuhrman, & McCandles,
1994; Egerod, 2002). In the absence of specific physician orders and the lack of sedation
protocol, many factors may influence nurse-driven sedation.
A rigorous qualitative study using focus group interviews of 34 ICU nurses with
at least six months of experience found that sedation therapy was significantly influenced
by social, personal, and professional factors (Weinert, Chian, & Gross, 2001). The lack of
a written order also allows for errors in the communication regarding sedation
management that may verbally occur between physicians and nurses. The perception of a
patient’s level of sedation varies between physicians and nurses and will not guide
sedation management consistently.
A survey of critical nurses and critical care physicians revealed that while both
felt they were providing adequate sedation only about 50% of the time, nurses were more
likely to feel that many of their patients were undersedated and physicians were more
likely to feel that many of their patients were oversedated (McGaffigan, 2002). The use
of sedation protocols to guide sedation along with sedation assessment tools attempts to
standardize sedation assessment and management among nurses and physicians.
While many ICUs still do not use sedation protocols (Weinert et al., 2001), there
are 23 published instruments (sedation scores or sedation scales) used to assess sedation
in adult ICU patients (Devlin, Fraser, Kanji, & Riker, 2001). Of these, only nine sedation
assessment instruments have undergone studies evaluating their validity and/or reliability
(Devlin et al.).
Subjective sedation assessment tools such as the Ramsay Sedation Scale (RSS)
(Shah, Clack, Chea, Tayong, & Anderson, 1996), the Sedation Agitation Scale (SAS)
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(Simmons, Riker, Prato, & Fraser, 1999; York, Boysen, & O’Kane, 2000) and the
COMFORT scale (Hansen-Flaschen, Cowen, & Polomano, 1994) have been shown to be
reliable and valid. While all three scales have been shown to correlate with the objective
measurement of the BIS (Hansen-Flaschen, Cowen, & Polomano; Shah et al.; Simmons
et ah), they, unlike the BIS, are extremely limited in their use for patients that cannot
respond effectively to stimuli, as with aggressive sedation, neuromuscular blockade, and
barbiturate coma (Arbour, 2000a; De Deyne et ah, 1998). The BIS differs from the
established subjective sedation instruments in that it provides an objective, quantified
value of the depth of sedation independent of patient movement or participation.
BIS technology evolved from the search for a measure of central nervous system
depression that would serve as a monitor of anesthesia (Chan & Gin, 2000). As a useful
tool for measuring the level of sedation in the OR, BIS has improved patient outcomes,
increased time efficiency in the OR, and reduced costs (Glass & Johansen, 1998). The
applications and positive impacts of the BIS in the ICU and special procedure
environments that provide sedation are becoming apparent. BIS was described recently
by a BIS Clinical Specialist as, “.. .strictly a monitor for sedation and hypnosis and not a
measure for paralytics or analgesics given at the same time,” (D. Mazurek, personal
communication, February 29, 2003). However, indirect measurement of analgesia is just
one of the potential BIS applications that has shown encouraging results.
Beyond Sedation Management: Potential BIS Applications in the ICU
BIS use in the ICU has many potential applications. Although FDA-approved
only as a measure of sedation, significant research is validating the clinical usefulness of
the BIS in other patient populations. Alternative uses include indirect measurement of
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analgesia effects on the brain, correlation with neurological status of unsedated patients,
monitoring depth of sleep, and ensuring comfort in palliative care.
Indirect Measures o f Analgesia Effects on the Brain
Bloom, Greenwald, and Day (1996) utilized 588 assessments of sedation from a
previously reported volunteer study using a dose-stepping sequence of sedatives to
achieve predetermined drug levels. A comparison of BIS response before and after
stimulation was made between subjects who received analgesics prior to the stimulation
and those who did not. The study found that the increase in BIS in response to
stimulation was significantly less in those subjects who received analgesics (p<0.05).
The ability of analgesics to decrease arousal from stimulation and decrease unstimulated
variability in the BIS aids in the clinical interpretation of BIS (Bloom, Greenwald, &
Day).
A similar study was conducted on a patient receiving neuromuscular blocking
agents. After the endotracheal suctioning was performed on this patient, a dramatic
arousal of BIS (greater than 80) was elicited, following a return to baseline after
suctioning was completed (Arbour, 2000b). Prior to repeating the endotracheal
suctioning, lidocaine was instilled into the endotracheal tube through a suction catheter;
this time the suctioning resulted in no arousal response, or risk of breakthrough
awareness (Arbour, 2000b). While unable to predict arousal, the BIS may be able to aid
in the determination of an adequate analgesic state and assess the arousal response to
stimuli in the ICU with implications for decreasing the adverse effects of noxious stimuli.
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BIS Correlation with Neurological Status
Neurological status has also been shown to correlate with BIS values. Bilateral
BIS monitoring of 47 patients (59% male) found that ICU patients with abnormalities on
brain CT scans had asymmetric BIS values, usually lower on the injured side (Riker,
Fraser, Wilkins, Schlichting, & Prato, 2000). Another study of 31 awake, unsedated
critically ill adults with varied neurologic status assessed subjects with the BIS in 108
separate sessions to determine that BIS was significantly (p<0.05) correlated with
neurolgic score, with better neurologic function associated with higher BIS values
(Gilbert, Wagner, Halukurike, Paz, & Garland, 2001). An implication of this study may
include an attempt to adjust the BIS ranges to correlate with sedation levels in patients
with decreased neurologic function (lower baseline BIS) to achieve the intended level of
sedation. Conversely, further research may determine that the effects of changes in
neurologic status and pharmacologic sedation upon the EEG are additive. Chan and Gin
(2000) also point out that careful correction of EEG slowing due to hypothermia and
cerebral ischemia is necessary to avoid serious misinterpretation of the reduced BIS
value.
BIS Monitoring in Depth o f Sleep
Sleigh, Andrzejowski, Steyn-Ross, and Steyn-Ross (1999) concluded that the
electroencephalographic changes noted during increasing sleep depth are similar to those
noted during increasing anesthesia. The study of Sleigh et al. included 5 healthy
volunteers who were monitored with BIS in their natural sleep environment during the
early part of the night. While BIS correlated with increasing depth of sleep, the authors
only divided the sleep stages into light sleep (high-frequency/low-amplitude) and deep
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sleep (slow-wave, or high-amplitude/low-frequency). Since all four of the identified
stages of sleep were not used, this was a limitation of this study (Sleigh et al.).
In a subsequent study, 10 patients suspected of having mild sleep apnea/hypopnea
syndrome (4 of the patients met criteria) were additionally monitored with the BIS during
routine EEG testing (Nieuwenhuijs, Coleman, Douglas, Drummond, & Dahan, 2002).
This study by Nieuwenhuijs et al. refutes the findings of Sleigh et al., due to the overlap
of BIS values during “light sleep” (stages one and two) and “deep sleep” (stages three
and four). Therefore, the use of BIS in sleep studies is controversial and understudied.
Additionally, both studies failed to discriminate between all stages of sleep and included
small sample sizes with limited generalizability.
Utilizing BIS for Palliative Care
Palliative care often refers to provision of comfort for terminal patients,
accompanied by the reduction of technological support and therapies. Life-sustaining
support, such as mechanical ventilation, may already be in place when the decision is
made to provide the patient with comfort measures only. Withdrawal of mechanical
ventilation may occur by extubation (removal of the breathing tube) or via terminal
weaning, in which support is gradually reduced. Campbell, Bizek, and Stewart (1998)
present the case of a blind 77-year old man who became paralyzed after a fall and was
apneic, yet conscious and able to indicate his wishes for withdrawal of mechanical
ventilation. In this case, the BIS was instrumental in providing data to the medical team
and family members regarding the patient’s awareness and comfort level so that effective
sedation and analgesia could be administered when other objective signs, such as
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spontaneous movement, and physiological parameters, including respiratory rate and
heart rate, were unavailable or unreliable (Campbell, Bizek, & Stewart).
Conflicting BIS Data: Need for Clinical Correlation of Data
Research has confirmed BIS usefulness in sedation therapy during neuromuscular
blockade or barbiturate coma, but also concludes that significant variability and
interferences with data may occur (Devlin et al., 2001). Appropriate use of BIS
technology includes utilizing EMG, SQI, and SR data within clinical circumstances to
identify and eliminate potential artifacts (contaminants) in the digital BIS reading.
The small electrical signals produced by the brain are vulnerable to contamination
by other sources of electrical noise that may have similar high-frequencies, such as EMG
signals, electrocardiographic (ECG) signals, and signals produced by electrical devices
used during surgery or in the ICU. The BIS algorithm may be affected by the non-EEG
signals that have overlapping frequencies with those of the EEG, as these interfering
signals at similar frequencies cannot be completely eliminated or the EEG signal would
be lost as well. Since muscle activity (EMG) is often associated with an awakening
patient, it may be appropriately associated with an increase in BIS. However, a burst of
muscle activity or increase in muscle tone with a sudden rise in BIS despite adequate
sedation may cause excessive EMG influence on the BIS, resulting in a BIS value much
higher than indicated in the EEG data alone (Aspect Medical Systems, Inc., n.d.). The
EMG is seen as a horizontal bar on the BIS monitor, which lengthens with increased
EMG activity. If the sedative is not being weaned off, sources of increased EMG such as
shivering, wrinkling of the forehead, grimacing, seizure activity, subtherapeutic NMB
therapy, and close use of electrical signal producing devices should be assessed. Also
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notable is the 15-30 second delay in computation of the BIS value. Increases in EMG will
not immediately affect the digitalized BIS value, but can be seen as an increase on the
EMG bar display. Furthermore, an elevated BIS value may be the result of a transient
increase in EMG that has already subsided.
The SQI bar display on the BIS monitor should also be assessed. For this
parameter, a lengthened bar also indicates increased SQI, which is desirable as it shows
that usable data is being produced. The longer the SQI bar reads, the greater the
percentage of usable data over the last minute. If the SQI reads less than 50%, the BIS
display changes from a solid number to an outlined number. The decreased SQI alerts the
user to check electrodes for adherence and eliminate other impedances to obtain a better
quality signal.
Despite the vast potential interferences with signal quality, a study by
De Deyne et al. (1998) confirmed the ability of BIS technology to provide a high quality
signal in the ICU with an SQI always greater than 80% throughout two hours of BIS
monitoring on 18 sedated, surgical ICU patients. Furthermore, while noting SQI less than
25% for greater than 20% of the recording time over 24 hours for 5 of 19 ICU patients, as
well as EMG greater than 50 decibels (greater than brain electrical activity) for greater
than 20% of the same recording time, Johansen (n.d.) still found that greater than 85% of
the recordings met acceptable thresholds for BIS interpretation. Thus, while interferences
can and will make some BIS data unusable, the majority of the data is valid and reliable
when assessed.
The SR is also available on the BIS monitor as a number indicating the percentage
of the last minute having suppressed, or isoelectric, brain activity. Titration of
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barbiturates to a burst-suppression pattern was discussed regarding BIS use in a
barbiturate coma. While the EEG changes occurring with burst suppression would affect
the BIS value, it may be difficult to determine when the exact deep sedation needed to
achieve this affect is achieved based on the BIS value alone. The SR value can be
assessed for increasing isoelectric activity that would indicate deeper anesthesia or
barbiturate coma, as an adjunct to the BIS value. The value of the SR correlation was
noted by Bruhn, Bouillon, and Shafer (2001) when BIS values between 30 and 40 did not
reflect increased propofol effect, yet a burst suppression pattern appeared on the EEG. In
addition to assessing the SR, the authors suggest choosing the suppression ratio as a
second trend line on the monitor or inspecting the raw EEG for the burst suppression
pattern (Bruhn et al.).
Summary
The review of the literature reveals the need for sedation and adjunct therapies in
the ICU. The vital component of sedation assessment for optimal sedation management
was also reviewed with subjective and objective sedation assessment methods discussed.
The ability of the BIS to provide objective sedation assessment was shown with a
discussion of approved and potential applications of the BTS in the ICU. Integral to this
review was the vital role of the critical care nurse in sedation management of the ICU
patient. The nurse’s ability to comprehensively interpret the BIS in the ICU directly
affects its usefulness for sedation management in this critically ill patient population.
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Definitions
The following terms of this independent study have been defined:
Agitation: excessive, usually nonpurposeful, motor activity often associated with
increased muscle tone and catecholamine levels (major elements in stress response).
Analgesia: a neurologic or pharmacologic state in which painful stimuli are so
moderated that, though still perceived, they are no longer painful.
Attitude: feelings or thoughts that show one’s disposition, opinion, or mental set.
Anxiety: a prolonged state of apprehension in response to a real or perceived fear.
Behavior: the way a person acts or conducts oneself in a particular environment or
in response to stimulation.
Bispectral Index (BIS): technology developed by Aspect Medical Systems that is
FDA-approved and commercially available to monitor the effects of anesthetics and
sedatives and on the level of consciousness in the Operating Room, Intensive Care Unit,
and special procedure environments where sedation is administered.
Consciousness: the state of being aware, or perceiving physical facts or mental
concepts; a state of general wakefulness and responsiveness to environment.
Critical Care Nurse: a licensed health professional, either a Registered Nurse
(RN) or a Licensed Practical Nurse (LPN), who is responsible for assessing, planning,
implementing, evaluating, and documenting the care of patients in an ICU/CCU. Provides
bedside care and carries out medical regimens. The critical care nurse is responsible for
ensuring that all critically ill patients and their families receive optimal care (T. Wavra,
American Association of Critical Care Nurses, personal communication, April 15, 2003).
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In this setting, a critical care nurse is almost exclusively a RN, but a LPN may practice in
the ICU within the scope of their license and nurse practice act. Under the facility’s job
description, the LPN is to ensure that the assessment is reviewed by an RN. Additionally,
the LPN consults with the RN in developing the plan of care.
Critically 111 Patient: a patient at high risk for actual or potential life threatening
health problems. Increasing critical illness increases the likelihood that the patient is
highly vulnerable, unstable, and complex (T. Wavra, American Association of Critical
Care Nurses, personal communication, April 15, 2003).
Deep Sedation/Analgesia: is defined by the American Society of
Anesthesiologists (ASA) (2001):
Deep Sedation/Analgesia is a drug-induced depression of consciousness during
which patients cannot be easily aroused but respond purposefully following
repeated or painful stimulation. The ability to independently maintain ventilatory
function may be impaired. Patients may require assistance in maintaining a patent
airway, and spontaneous ventilation may be inadequate. Cardiovascular function
is usually maintained, (p. 24)
General Anesthesia: is defined by the ASA (2001):
General Anesthesia is a drug-induced loss of consciousness during which patients
are not arousable, even by painful stimulation. The ability to independently
maintain ventilatory function is often impaired. Patients often require assistance
in maintaining a patent airway, and positive pressure ventilation may be required
because of depressed spontaneous ventilation or drug-induced depression of
neuromuscular function. Cardiovascular function may be impaired, (p. 24)
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Intensive Care Unit (ICUVCritical Care Unit (CCU): a hospital environment that
provides comprehensive treatment for critically ill patients.
Knowledge: a clear perception or understanding of a person, place, thing, or idea.
Level II Trauma Center: as defined by the American College of Surgeons (ACS)
Committee on Trauma (COT) (1998):
The Level II Trauma Center provides comprehensive trauma care in two distinct
environments which have been recognized in the ongoing verification program
sponsored by the ACS COT. The first is in a population-dense area where a Level
II supplements the clinical activity and expertise of a Level I institution [...] The
second Level II environment occurs in less population-dense areas. The Level II
hospital now serves as the lead trauma facility for a geographic area, as a Level I
institution is not likely to be geographically close. [...] This lead trauma hospital
is expected to have an outreach program which incorporates smaller institutions in
their service area. Transfer arrangements with distant Level I or II institutions are
dictated by local resources, (p. 11)
Minimal Sedation (Anxiolysis): is defined by the ASA (2001): “Minimal Sedation
(Anxiolysis) is a drug-induced state during which patients respond normally to verbal
commands. Although cognitive function and coordination may be impaired, ventilatory
and cardiovascular functions are unaffected” (p. 24).
Moderate sedation/Analgesia (“Conscious Sedation”): is defined by the ASA
( 2001 ):

Moderate Sedation/Analgesia (“Conscious Sedation”) is a drug-induced
depression of consciousness during which patients respond purposefully
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following repeated or painful stimulation. The ability to independently maintain
ventilatory function may be impaired. Patients may require assistance in
maintaining a patent airway, and spontaneous ventilation may be inadequate.
Cardiovascular function may be impaired, (p. 24)
Neuromuscular Blockade: the intentional interruption of transmission at
the neuromuscular junction (the chemical synapse between a motor neuron and a
muscle fiber) by external agents, usually neuromuscular blocking agents. It is
commonly used to produce muscle relaxation as an adjunct to anesthesia during
surgery and other medical procedures.
Sedation: the act of calming, especially by the administration of a
sedative; the state of being calm.
Sedative: A drug that quiets nervous excitement; designed according to the
organ or system upon which specific action is exerted.
Skill Competency Validation: a document that serves as a record for
nurses and facilities of nursing competency of a specific skill.
Skill Validation: A process that provides consistent information and
training on specific procedure(s) or equipment, requiring nurses to articulate
and/or demonstrate knowledge of a specific skill.
Stress: reactions of the body to forces of a harmful nature, infections, and
various abnormal states that tend to disturb its normal physiologic equilibrium
(homeostasis).
Train-of-four (TOF) method: objective measurement of neuromuscular
blockade in which a series of four electrical currents are applied to a peripheral
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motor nerve with the resulting number of twitches relating to a percentage of
receptor sites occupied by the neuromuscular blocking agent. Zero twitches
indicate 100% blockade, two twitches indicate 75-85% blockade, three twitches
indicate about 75% blockade, and four twitches indicate less than 75% blockade
of the receptors.
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CHAPTER III
METHODOLOGY OF THE INDEPENDENT STUDY
This independent study developed a procedure (Appendix A) and SCV (Appendix
B) for BIS utilization in the ICU by critical care nurses. Following implementation of the
procedure and SCV, critical care nurses were asked to complete an evaluation tool
(Appendix C) that aimed to assess whether the goal of providing direction for sedation
management through research-based guidelines on BIS use in the ICU had been attained.
Population
The population for which a procedure and SCV for BIS use in the ICU was
developed was critical care nurses working in a city with approximately 60,000 people
within an upper Midwest rural state. The nurses worked in a regional Level II Trauma
Center licensed for 277 beds, including a 10-bed surgical ICU and a 16-bed cardiac ICU.
Nurses required to be knowledgeable of all mandatory procedure and SCV have either
regularly scheduled hours, or are of flex-time status in their critical care unit, in which
they work a minimum of one weekend per month. Critical care nurses of the employment
statuses included are required to complete and maintain equal procedure and SCV
education training for their positions. Nurses working occasionally in the critical care unit
who are not required to maintain equivalent training were not included.
Sample
All nurses meeting the inclusion criteria of the population were included in the
sample. Participants not completing their mandatory education within the three months
allotted for the implementation and evaluation of the independent study had the potential

to limit the sample size. All nurses in the sample, those that have been instructed on the
BIS procedure and SCV, were given the opportunity to complete the Evaluation of the
BIS Procedure and Skills Validation.
Methodology/Procedures
This graduate student met with the two critical care nurses responsible for
implementing unit-specific nursing education in the ICUs for which the procedure and
SCV was developed. With their additional input, the procedure and SCV for BIS use in
the ICU was developed based on its FDA-approved use and applications proven useful
through research. After approval of the procedure and SCV by these unit nurse educators,
the independent study was placed on the agenda of the ICU committee, a meeting that
brings together the nurse educators and critical care physicians. After revision and
approval at this meeting, the procedure and SCV was taken before the facility’s skill
validation/policy and procedure committee for approval. Minor revisions were made and
the procedure and SCV was approved for utilization in the ICUs. Implementation of the
BIS procedure was concurrent with the BIS SCV and both became mandatory education
for all critical care nurses.
The BIS procedure outlined use of the BIS. It included instructions on
patient identification for BIS monitoring, set-up, monitoring functions, and analysis of
BIS data in the ICU. The BIS SCV was a checklist of competency in BIS use that nurses
must complete with the unit nurse educator after reviewing the BIS procedure.
The two critical care nurses responsible for implementing unit-specific nursing
education in the ICUs instructed the ICU nurses on the BIS procedure and SCV. On a
weekly basis, the graduate student contacted the educators for an update on which nurses
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had received this BIS education so that they could be contacted for an evaluation. The
ICU nurses were sent a message via the hospital computer system explaining that
development of the BIS procedure and SCV was part of the requirements for the graduate
student’s degree in anesthesia nursing and their completion of the Evaluation of the BIS
Procedure and Skills Validation would be greatly appreciated. The nurses were also told
that the evaluation was placed in their inter-office mailbox and could be returned
anonymously to the graduate student’s inter-office mailbox via inter-office mail.
Contacting the nurses that had received education with the BIS procedure and SCV in the
previous week continued for a period of three months to allow the unit nurse educators
sufficient opportunity to provide this mandatory education to the critical care nurses.
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CHAPTER IV
RESULTS
After approval from the critical care unit nurse educators, the ICU committee, and
the facility’s skill validation/policy and procedure committee, three months were allotted
for implementation of the independent study. At the conclusion of the three months
allowed for implementation of the BIS procedure and SCV, evaluation forms were
collected and analyzed. Of the 67 nurses (total for both ICU units) that met the population
criteria, 32 nurses received the BIS procedure and SCV education within the independent
study’s time frame. Of the 32 nurses who were given the opportunity to complete an
Evaluation of the BIS Procedure and Skills Validation, 23 nurses completed and returned
their evaluation.
In the evaluation, nurses were asked to provide their opinion on how much they
agreed with six statements regarding their understanding of indications for BIS use and
their preparation to utilize the BIS with ICU patients. Next, they were asked to identify
five statements regarding ICU considerations for BIS use as either true or false.
Statement 1 stated, “I understand the indications for BIS use in ICU patients.” Of
the 23 nurses that completed an evaluation, 39% (n= 9) strongly agreed, and
61% (n=14) agreed with this statement.
Statement 2a stated, “I am adequately prepared to utilize BIS with patients
receiving continuous IV sedation in the ICU in regards to BIS monitor set-up.” Fortythree percent (n = 10) of the nurses strongly agreed, and 48% (n=l 1) agreed with

this statement. The remaining 9% (n = 2) were neutral in their opinion regarding their
preparation to set-up the BIS monitor.
Statement 2b stated, “I am adequately prepared to utilize BIS with patients
receiving continuous IV sedation in the ICU in regards to sensor application.” Fifty-seven
percent (n = 13) of nurses strongly agreed with this statement, and 39% (n = 9) agreed
with this statement. Only 1 nurse (4%) was neutral in his/her opinion of this statement.
Statement 2c stated, “I am adequately prepared to utilize BIS with patients
receiving continuous IV sedation in the ICU in regards to initiation of BIS monitoring.”
Forty-three percent (n = 10) of nurses strongly agreed and 52% (n = 12) agreed with this
statement. One nurse (4%) was neutral in his/her opinion of this statement.
Statement 2d stated, “I am adequately prepared to utilize BIS with patients
receiving continuous IV sedation in the ICU in regards to knowledge of monitor display
features (BIS number, SQI, EMG, EEG, SR).” Only one nurse (4%) strongly agreed with
this statement, 78% (n = 18) agreed, and 17% (n = 4) were neutral in their opinion.
Statement 2e stated, “I am adequately prepared to utilize BIS with patients
receiving continuous IV sedation in the ICU in regards to documentation requirements.”
Twenty-six percent (n = 6) of nurses strongly agreed with this statement, 61% (n = 14)
agreed, and the remaining 13% (n = 3) were neutral in their opinion.
The first true/false statement stated, “BIS readings should be interpreted over time
and in response to stimulation, and in the context of patient status and treatment plan.”
Ninety-six percent (n = 22) nurses correctly identified this as a true statement.
The second true/false statement stated, “Movement does not occur with low BIS
values.” Seventy percent (n = 16) of nurses correctly identified this statement as false.
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One nurse that identified this statement as true justified his/her answer with “i.e. 20-40
(general anesthesia range).” While general anesthesia may eliminate movement through
muscle relaxation, it is not an absolute, and some agents capable of producing general
anesthesia such as barbiturates do not produce muscle relaxation. Methohexital, a
barbiturate, may actually induce involuntary muscle contractions. While this statement is
directly from the BIS procedure, there is no explanation in the procedure of why the
movement may occur. During the validation process, it may be helpful to discuss specific
effects of sedatives and general anesthetics vs. paralytics, as well as noting the potential
for pain to cause movement even with deep sedation.
The third true/false statement addresses the role of BIS in indi rectly measuring
analgesia. It stated, “Movement may indicate inadequate analgesic level.” Seventy-four
percent (n = 17) of nurses correctly identified this statement as true. If movement cannot
indicate inadequate analgesic level, as proposed by the other 26% (n

6) of the nurses

that identified this statement as false, then movement occurring with adequate sedation
(which does not provide analgesia) may be treated incorrectly with further, unnecessary
sedation and/or paralytics. Also interesting is that of the 6 nurses who were not aware that
movement may indicate inadequate analgesic level, only 1 nurse (17% of the 6 nurses
who answered the third true/false statement incorrectly) strongly agreed with statement 1
(“I understand the indications for BIS use in ICU patients”), compared with an overall
39% (n = 9) that strongly agreed with statement 1.
The fourth true/false statement stated, “The usual goal for the BIS number in the
ICU setting is in the range of 40-60.” All 23 nurses (100%) correctly identified this
statement as true.
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The fifth true/false statement stated, “The BIS display reflects real time status of
the sedation level (there is no delay).” Seventy-four percent (n = 17) of nurses correctly
identified this statement as false. The 15 or 30 second delay in configuring the BIS
(smoothing rate) must be accounted for when interpreting BIS readings as the stimulus
that causes an acute increase in BIS may have already ended when the nurse recognizes
the increased BIS value and may not require a change in the sedation plan. An example
would be the increase in BIS after endotracheal tube suctioning. Increasing sedation, or
analgesia, after the completion of suctioning will not alter the effects of this stimulus.
However, recognizing that the suctioning occurring 30 seconds prior to the increase in
BIS was the cause of the increase may lead the nurse to provide analgesia or local
anesthetic spray prior to suctioning the next time.
A greater percentage of nurses who correctly answered all five of the true/false
statements strongly agreed with statements 1 (understanding BIS indications), 2a, 2b, and
2c (feeling adequately prepared regarding BIS set-up, sensor application, and monitoring,
respectively) than those who incorrectly answered one or more of the true/false questions
(44% vs 36%, 56% vs 36%, 78% vs. 43%, and 56% vs 36%, respectively). Also, a
greater percentage of nurses who correctly answered all five of the true/false statements
strongly agreed or agreed with statements 2d and 2e (knowledge of monitor display
features and documentation requirements, respectively) than those that incorrectly
answered one or more of the T/F questions (88% vs. 79% and 89% vs. 86%). Therefore, a
correlation exists between nurses who were more knowledgeable about ICU
considerations for BIS use and those who felt they understood the indications for BIS
use and felt they were prepared to use the BIS in ICU patients.
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CHAPTER V
DISCUSSION AND CONCLUSIONS
This independent study has developed a procedure and SCV for BIS utilization in
the ICU by critical care nurses in relation to the concepts of sedation and analgesia.
The ability of this procedure and SCV to aid in directing nursing use of BIS for sedation
management in the ICU is discussed with potential implications for nursing practice,
education, policy and research.
Implications for Nursing Practice
The major implication for nursing practice is to utilize the findings of the
Evaluation of the BIS Procedure and Skills Validation to further educate critical care
nurses regarding the indications and usage of BIS for ICU patients. Areas for future
education and the implications of erroneous knowledge in these areas were discussed
previously in the results section. Statement 2d had the fewest nurses in agreement. It
identified that only one nurse (4%) strongly agreed that he/she was prepared to utilize
BIS with patients receiving continuous IV sedation in the ICU in regards to knowledge of
monitor display features. Another 78% (n = 18) agreed, and 17% (n =: 4) were neutral in
their opinion. Since monitor display features are more applicable and easier to understand
when the BIS monitor is actually in use, I would recommend that the hospital follow up
on this with a buddy system or some kind of available assistance to aid the newly
educated nurse with his/her first few BIS usages .
Through a continuous process of education and evaluation, critical care nurses
will have the knowledge necessary to optimize BIS use in the ICU. Additionally, other

areas where nurses may use the BIS monitor for sedation management can adapt the BIS
procedure and SCV to meet their needs. These areas may include the operating room,
pediatric ICU, and the emergency room.
Implications for Nursing Education
As critical care nurses become more educated about sedation monitoring and are
appropriately equipped to do so, education will focus on maintaining a level of optimal
sedation management of the ICU patient. Until then, the quest to provide consistent,
uniform knowledge must continue to evolve through mandatory education and a careful
assessment of post-education evaluation results, followed by appropriate adjustments in
the educational process.
As a practicing critical care nurse, efforts to conduct or incorporate others’ current
research regarding sedation management into practice is also necessary to achieve
and maintain optimal sedation for the ICU patient. With the availability of research-based
guidelines, critical care nurses can base their judgements and decisions regarding patient
sedation on factors that will promote the best outcome.
Implications for Nursing Policy and Research
Follow-up studies to identify the success of further BIS procedure and SCV
implementation may be the focus of future nursing research. Research studies that
identify nurses’ subjective opinions regarding BIS use may also more precisely direct
further education. Undoubtedly, research to prove the usefulness of the BIS in clinical
situations beyond sedation assessment and management will continue. Future studies or
investigations could also compare and contrast BIS with its competitor, the PSA 4000
sedation monitor. The PSA 4000 technology was developed by Phsiometrix and is
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marketed by Baxter Healthcare as a sedation assessment and management tool. Its system
includes the Pateint State Index (PSI), a 4-channel processed EEG parameter. This
product received FDA clearance for its consciousness-monitoring system and ‘frontal
array’ sensor on October 8, 2002 (Physiometrix, 2002). It has been available for trial in
the OR of the facility for which this BIS procedure and SCV was developed. Additional
studies within the hospital could focus on the frequency of sedation monitor usage and
associated outcomes. Are we using this technology to the extent that we should be to
optimize sedation management for our patients?
This independent study could provide the basis for clinical guidelines regarding
sedation management in all areas of the facility. At the state and national level,
conscious sedation has gained strict guidelines for use regarding available personnel and
equipment. Continuous sedation requires the same vigilance to avoid the potential
complications from long-term undersedation and oversedation that were previously
discussed.
Summary
The purpose of this independent study to develop a procedure and SCV for BIS
utilization in the ICU by critical care nurses in relation to the concepts of sedation and
analgesia was met. The BIS procedure and SCV is now available to direct nursing use of
BIS in the ICU. Its aim to provide consistent education to critical care nurses regarding
BIS technology usage and limitations is being met. The evaluation tool that assessed the
usefulness of the procedure and SCV for directing nursing use of BIS in clinical practice
and provided an assessment of their understanding of the education they received has
shown promising results. Statements regarding critical care nurses’ comfort with
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providing sedation monitoring via BIS in the ICU were agreed or strongly agreed with by
92% of the critical care nurses who completed the evaluation. Additionally, 83% of the
true/false statements that assessed nursing knowledge regarding the procedure and SCV
were answered correctly overall. Thus, the development and initial implementation of the
BIS procedure and SCV for critical care nurses has been successful and will prove
essential in helping nurses optimally manage sedation for patients in the ICU.
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APPENDIX A
BIS PROCEDURE

ALTRU HEALTH SYSTEM
Grand Forks, ND
STANDARD PROCEDURE
Title:

BISPECTRAL INDEX (BIS) MONITORING SYSTEM
Issued by:
Date:
Reviewed:
Revision:
Page:

Critical Care
1/04
1 of 4

PURPOSE: To provide accurate assessment of the degree of sedation in
'patients who are receiving continuous IV sedation.
AUTHORIZED PERSONNEL:

Skills Validated RN, CRNA

EQUIPMENT:
1.
2.
3.
4.

A-2000 BIS monitor with power cable and DSC cable
BIS extend-XP sensor
Alcohol wipe
IV pole

PROCEDURE:
BIS monitoring is mandatory with continuous IV sedation and paralysis.
For continuous IV sedation only, consult with physician regarding use
of BIS.
1.

After rec’
eiving order for BIS use, obtain equipment for BIS
monitoring and clarify sedation goals (e.g., BIS range) with
physician.

2.

Provide teaching on BIS monitoring to patient/family.

3.

Setup BIS monitor.
a.
b.

4.

Ensure power cable is connected to back of monitor.
Ensure DSC cable is connected to front of monitor.

Sensor application.
a.
b.
c.
d.
e.
f.
g.

Wipe skin with alcohol and allow to dry for 30 seconds.
Record date and time of application on sensor strip where
indicated.
Apply sensor #1 on forehead so that line on sensor is
parallel to nose, in center of forehead 2 inches (5cm) above
nose.
Apply sensor #4 directly above and parallel to eyebrow.
Apply sensor #3 on temple area between corner of eye and
hairline.
Apply sensor #2 (located between sensors #1 and #3).
Press edges of sensor circles to assure adhesion.
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h.

Press circles 1, 2, 3, and 4 firmly for 5 seconds to assure
proper contact.
Insert sensor tab into patient interface cable
(PIC),
located on unattached end of DSC cable, until engaged.

i.
NOTE:
5.

Replace sensor within 24 hours.
When
sensor, press release button on PIC.

disconnecting

Initiation of BIS monitoring.
a.
b.

Attach BIS monitor to IV pole at bedside.
Turn machine on by pressing black button on the right lower
side of monitor.
Allow BIS monitor to perform impedance besting of sensors.

c.
NOTE:

6.

•

BIS monitoring will not begin until all impedances are
acceptable.
If
sensor
expired message
appears,
press
menu/exit key to initiate impedance testing.

»

If impedance testing is not in pass range, press on
identified sensors.
If no improvement, replace sensor and
return to Step 4.

Monitor display features.
a.

Bispectral Index display region (BIS number):
digital
readout ranging from 0-100, with zero indicating absence of
electrical brain activity and 100 indicating a fully awake
state.
BIS ranges should be dependent upon the individual
goals for sedation that have been established for each
patient.
Usual goal for ICU patients is 40-60, indicating
low probability of explicit recall and unresponsiveness to
verbal stimulus, rendering the patient in a state of deep
sedation.
NOTE:

There is a 15-30 second delay in the calculation
of the BIS number from raw EEG data.

b.

Signal Quality Index (SQI): Ranges from 0-100% and is an
indicator of quality signal.
It is optimal when bar extends
to the right.
If SQI reads <50%, the BIS display changes
from a solid number to an outlined number.
The decreased
SQI alerts the user to check electrodes for adherence and
eliminate other impedances to obtain a better quality
signal.

c.

Electromyography (EMG): Depicts presence of muscle activity
or high frequency artifacts (ventilators, warming blankets,
fluid warmers, oscillating mattresses) . EMG is increased as
the bar extends to the right and BIS should be interpreted
with caution when it is present.
I
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NOTE:

Muscle activity
(EMG)
is associated with an
awakening
patient
and
may
be
appropriately
associated with an elevated BIS.

Reminder: BIS display reflects status 15-30 seconds prior.

7.

d.

Electroencephalography (EEG): A graphic display of measured
electrical brain activity.
A low amplitude, high frequency
waveform indicates a more awake state.
A higher amplitude,
lower frequency waveform indicates a state of deep sedation.

e.

■ Smoothing Rate (or Averaging Time) :
Is the time period
(e.g., 15 or 30 seconds) over which artifact-free data is
analyzed to calculate the BIS value.
A smoothing rate of 15
or 30 seconds may be chosen by pressing menu/exit key, down
arrow to BIS smoothing rate, select button to choose 15 or
3 0 seconds, then press menu/exit key to return to display
screen.
Machine default for smoothing rate is a 30-second
delay.

f.

Suppression Ratio (SR): the % of time in the last minute
that the EEG signal is considered suppressed.

ICU Considerations.
a.

Reliance on the BIS alone
recommended.

for sedation management

is not

b. • Clinical judgment should always be Used when interpreting
the BIS in conjunction with other available clinical signs.
c.

BIS readings should be interpreted over time and in response
to stimulation, and in the context of patient status and
treatment plan.

d.

Movement may occur with low BIS values.

e.

Movement (EMG) may indicate inadequate analgesic level.

f.

Artifacts and poor signal quality may lead to unreliable BIS
values.
Potential artifacts may be caused by poor skin
contact, muscle activity or rigidity, head and body motion,
sustained eye movements, improper sensor placement or skin
preparation, and unusual or excessive interference.

g.

BIS values should be interpreted cautiously in patients with
known neurological disorders, in those taking psychoactive
medications and in children less than 1 year old.

h.

Natural sleep cycles may affect the hypnotic level.

*

►
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8.

C lin ic a l use.

a.

IV sedation should be titrated to maintain croal BIS range or
as directed by physician.

b.

BIS monitoring is to be implemented for all patients in
which continuous IV sedation is accompanied by paralysis.
When patients are receiving continuous IV' sedation only,
consider BIS use and consult with physician.
Considerations
include high doses or frequent boluses of IV sedation and/or
IV sedation expected to continue > 24 hours.

DOCUMENTATION:
i

*

1.

On Critical Care
value hourly.

2.

On Critical Care Flowsheet,
time of sensor application.

Flowsheet,

graphics

section,

treatment

section,

>

record

the

record date and

>
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BIS

APPENDIX B
BIS SKILL COMPETENCY VALIDATION

KILL COMPETENCY VALIDATION

Name: _______________________

[spectral Index (BIS)
mitoring System
scommended Completion Time:

ID# : __________ Dept: _______
Education Points: _____ 1.0
Issued By: _____ Critical Care
(Original) : _____ 1/04________
Reviewed/Revised Date: ______

3

Months

re-requisite: Watch "BIS" video and read BIS Procedure.
5JECTIVES - Upon completion the participant will be able to:
Demonstrate knowledge, use, and applications of Bispectral Index Monitoring
System.
DATE

SKILL
Demonstrate application of sensor to patient.
State how often to change sensor.
Demonstrate connecting sensor to monitor.
Describe what it means if BIS number is solid, is
outlined, or if it disappears.
Describe/demonstrate purpose of sensor check, impedance
check.
Define Signal Quality Index (SQI).
Describe Electroencephalogram (EEG) waveforms
significance.
Describe Electromyograph (EMG) significance.
Describe Suppression Ratio (SR) number significance.
Define smoothing rate.
State when BIS monitor should be used.
Discuss BIS numbers and what range is desired in the
ICU setting.
State required documentation.

lidator Initials: _______
rE - Dept.

YELLOW - Education

Signature: _____________________ Title:

PINK - Employee

*
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VALIDATOR

APPENDIX C
EVALUATION OF THE BIS PROCEDURE AND SKILLS VALIDATION

Evaluation of the BIS Procedure and Skills Validation
After completing the BIS education, please provide your opinion on how much you agree
with the following statements by using this scale: Strongly Agree = SA, Agree = A,
Neutral = N, Disagree = D, Strongly Disagree = SD.
I understand the indications for BIS use in ICU patients........ .... SA

A N

D SD

I am adequately prepared to utilize BIS with patients
receiving continuous IV sedation in the ICU in regards to:
a. BIS monitor set-up............................................................ .... SA

A N

D

SD

b. Sensor application............................................................. ....SA

A N

D

SD

c. Initiation of BIS monitoring....................................................SA

A N

D SD

(BIS number, SQI, EMG, EEG, SR)................................. .... SA

A N

D SD

e. Documentation requirements............................................ .... SA

A N

D SD

d. Knowledge of monitor display features

Please identify the following statements as True (T) or False (F) by circling T or F.
1. BIS readings should be interpreted over time and in response to stimulation,
and in the context of patient status and treatment plan.

T F

2. Movement does not occur with low BIS values.

T F

3. Movement may indicate inadequate analgesic level.

T F

4. The usual goal for the BIS number in the ICU setting is in the range of 40-60.

T

5. The BIS display reflects real time status of the sedation level (there is no delay). T

F
F

Thank you for completing this evaluation regarding BIS education. Your time is greatly
appreciated. Please return the evaluation to Twyla Kouba, SCCU via inter-office mail.
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